Assessment of Potential Interactions Between Cocaine and RPR 102681 - 1

National Institute on Drug Abuse (NIDA)16 enrolled

Overview

The purpose of this study is to assess Potential Interactions Between iv Cocaine and RPR 102681

Phase I, Double-Blind, Placebo-Controlled Dose Escalating Assessment of Potential Interactions Between Intravenous Cocaine and RPR 102681

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

DIAGNOSTIC

Masking

TRIPLE

Enrollment

Conditions

Cocaine-Related Disorders

Interventions

Cocaine-Related DisordersDRUG

Eligibility

Sex: ALLMin age: 18 YearsMax age: 45 Years

Medical Language ↔ Plain English

Inclusion Criteria: Includes but is not limited to: * Non-treatment seekers * DSM-IV criteria for cocaine abuse or dependence * Ability to verbalize understanding of consent form and provide written informed consent and verbalize willingness to complete study procedures; be able to comply with protocol requirements Exclusion Criteria: Please contact site for more information.

Locations (1)

Uniformed Services University of Health Science

Bethesda, Maryland, United States

Outcomes

Primary Outcomes

Hemodynamic response to cocaine and subjective response to cocaine

Time frame: 3x / 30 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.